About Xymera Bioscience Private Limited
Data last updated: 09 January 2026
Xymera Bioscience Private Limited is a private limited company based in Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 28 November 2016, the company has been in operation for over 10 years.
Registered with ROC Delhi under CIN U85100DL2016PTC308653.
Capital: an authorised share capital of ₹2 Lakh and a paid-up capital of ₹2 Lakh. Formerly known as Xymera Bioscience (Opc) Private Limited. It is led by directors Pradeep Manral and Ramashish Kukreti.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Office No – 223, Manglam Paradise Plot No 8 Sector 3 Rohini, Delhi, Delhi, India – 110085.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.71 Cr, a growth of 47% compared to the previous year.
As per MCA filings, the company has open charges of ₹30 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website xymerabioscience.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressOffice No – 223, Manglam Paradise Plot No 8 Sector 3 Rohini, Delhi, Delhi, India – 110085
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Xymera Bioscience Private Limited
Xymera Bioscience Private Limited has one previous CIN (Corporate Identification Number): U85100DL2016OPC308653. The current CIN is U85100DL2016PTC308653, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100DL2016PTC308653 | Current |
| U85100DL2016OPC308653 | Previous |
Business Activity of Xymera Bioscience Private Limited
Xymera Bioscience Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details for Xymera Bioscience Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Xymera Bioscience Private Limited
Xymera Bioscience Private Limited is audited by GROVER LUTHRA AND CHHABBRA for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GROVER LUTHRA AND CHHABBRA | Locked | Locked | Locked |
Complete auditor history for Xymera Bioscience Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Xymera Bioscience Private Limited
Xymera Bioscience Private Limited is currently managed by 2 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Pradeep Manral
Also directs:
Medzone Event Llp, Xymera Bioscience Private Limited
|
Director | 13 Aug 2022 | 3 Years 11 Months | Current |
|
Ramashish Kukreti
Also directs:
Medzone Event Llp, Xymera Bioscience Private Limited
|
Director | 13 Aug 2022 | 3 Years 11 Months | Current |
Financials of Xymera Bioscience Private Limited FY 2025 filings available
Xymera Bioscience Private Limited reported revenue of ₹3.71 Cr (up 47.00% YoY) for FY 2024.
Ten-year financial statements for Xymera Bioscience Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Xymera Bioscience Private Limited
Shareholding and ownership data for Xymera Bioscience Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Xymera Bioscience Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Aug 2024 | Hdfc Bank Limited | ₹30 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Xymera Bioscience Private Limited
View historical data on people associated with Xymera Bioscience Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Xymera Bioscience Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Xymera Bioscience Private Limited
GST registrations and filing compliance for Xymera Bioscience Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Xymera Bioscience Private Limited
Credit ratings, litigation, and regulatory alerts for Xymera Bioscience Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Xymera Bioscience Private Limited
MSME payment history for Xymera Bioscience Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Xymera Bioscience Private Limited
Corporate group structure for Xymera Bioscience Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Xymera Bioscience Private Limited
MCA filings and documents for Xymera Bioscience Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Xymera Bioscience Private Limited
Frequently Asked Questions about Xymera Bioscience Private Limited
Xymera Bioscience Private Limited is an active private limited company in the pharma sector based in Delhi, Delhi, India. It was incorporated on 28 November 2016 (10+ years old) and is registered under CIN U85100DL2016PTC308653.
Xymera Bioscience Private Limited reported revenue of ₹3.71 Cr for FY 2024 (up 47.00% YoY).
The current directors of Xymera Bioscience Private Limited are:
- Pradeep Manral - Director
- Ramashish Kukreti - Director
The primary industry of Xymera Bioscience Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Xymera Bioscience Private Limited can be reached at the registered office: Office No – 223, Manglam Paradise Plot No 8 Sector 3 Rohini, Delhi, Delhi, India – 110085, or through the website xymerabioscience.com.
The authorised capital is ₹2 Lakh, and the paid-up capital is ₹2 Lakh.